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ABASTRACT 
Background: Identifying protein functional sites (PFSs) and protein-ligand interactions 
(PLIs) are critically important in understanding the protein function and the involved 
biochemical reactions. As large amount of unknown proteins are quickly accumulated in this 
post-genome era, an urgent task arises to predict PFSs and PLIs at residual level. Nowadays 
many knowledge-based methods have been well developed for prediction of PFSs, however, 
accurate methods for PLI prediction are still lacking.  
Results: In this study, we have presented a new method for prediction of PLIs and PFSs 
based on sequence of the inquiry protein. The key of the method hinges on a function- and 
interaction-annotated protein domain profile database, called fiDPD, which was built from 
the Structural Classification of Proteins (SCOP) database, using a hidden Markov model 
program. The method was applied to 13 target proteins from the recent Critical Assessment 
of Structure Prediction (CASP10/11). Our calculations gave a Matthews correlation 
coefficient (MCC) value of 0.66 for prediction of PFSs, and an 80% recall in prediction of 
PLIs.  
 
Conclusions: Our method reveals that PLIs are conserved during the evolution of proteins, 
and they can be reliably predicted from fiDPD. fiDPD can be used as a complement to 
existent bioinformatics tools for protein function annotation. 
 
Key words: protein-ligand interaction; protein function-site; hidden Markov Model; SCOP; 
fiDPD; 
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Background 
Most proteins perform biological functions via interactions with their partners, such as small 
molecules or ligands, DNA/RNA, and other proteins, forming instantaneous or permanent 
complex structures. One important fact concerning protein-partner interactions is that only a 
few pivotal amino acids on protein surface play key roles in determining the interactions. 
Thus accurately predicting PFSs, and particularly identifying the types of interactions 
involved in these sites are extermemly important to correct annotation of protein functions, 
and thus providing valuable information for rational drug design and drug side-effect 
assessment[1-3]. Up-to-date, the 3D protein-partner complex structures are the main source 
of knowledge about PFSs and PLIs. In recent years, in silico methods have obtained 
increasing attentions as an alternative strategy for the annotation of protein function. This is 
due to the two contributions: the accumulation of a large number of 3D protein-complex 
structures in the publicly accessible Protein Data Bank (PDB)[4], and the fast development in 
computer technology and computation algorithms. In this post-genome era as piles of 
uncharacterized protein structure and sequence are quickly accumulated and freely accessible 
worldwide, a stringent task has arisen in the computational biology community: to develop 
accurate in silico method for prediction of PSFs and involved PLIs[5].  
 
In last decades computational methods had emerged to predict PFSs, which can be roughly 
grouped into two categories, namely the sequence-based methods and the structure-based 
methods[6]. Sequence-based methods assume that functionally important residues are 
conserved through evolution and might be identified as conserved sites based on multiple 
sequence alignment (MSA) within homologous protein families[7-9]. Sequence-based 
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information such as secondary structure propensity and the likely solvent accessible surface 
area (SASA) were also calculated and used to improve the function-site prediction[10-13]. 
Structure-based methods first determine the local or overall structural similarity between the 
enquiry protein and well-characterized proteins from PDB, and then predict function sites for 
unknown proteins using PFSs of known ones[14-17]. Typical local structural features include 
large clefts on protein surface[18, 19], special space-arrangement of catalytic residues[20-22], 
particular patterns between surface residues[23, 24], etc. Methods that used both structural 
and sequence information were also developed[25, 26], and when combined with artificial 
intelligence techniques they might give encouraging prediction results[27-29]. Other methods 
based on protein dynamics [30-32], protein-ligand docking and conventional molecular 
dynamics simulations [33-35] were also found successful in PSFs. 
 
As early as the emergence of the first protein-ligand complex structure, researchers had tried 
to characterize the interactions between proteins and ligands. Very recently, with the rapid 
accumulation of protein complex structures, structural bioinformatics approaches had been 
developed to characterize PLIs[36-41], and a bunch of atomic interaction databases were also 
generated to facilitate PLI studies[42-44]. These data offer new resource for prediction of 
PFSs and PLIs, and thus provide auxiliary information to facilitate conventional docking 
simulation and pharmacology researches. However, a systematic usage of these atomic 
interaction data in PFS prediction and protein function annotation is still lacking.  
 
Recently, we developed a time-efficient method, called fast dynamics perturbation analysis 
(FDPA), for prediction of ligand binding sites based on structural dynamic information [45-
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47]. The method was examined with a standard small-molecule docking test-set of 
GOLD[48], and for 94% of 305 protein complexes FDPA predictions find at least one true 
binding site. FDPA calculations support the idea that the PFSs tend to be associated with 
where an external interaction may cause large change in protein conformational distribution. 
Very recently, we applied FDPA to all available protein domain structures recorded in 
structural classification of protein database (SCOP)[49], and created a functionally annotated 
domain profile database (fDPD)[50]. In fDPD, similar SCOP domain structures are grouped 
into a profile module on which pivotal sites are marked by mapping PFSs of known proteins 
in the group. For an inquiry protein, the best-matched modules in fDPD are identified based 
on sequence similarity, using the profile hidden Markov model of HMMER program[51]. 
Finally, pivotal sites of the modules are collected and ranked as a prediction of PFSs of the 
inquiry protein. The method had been examined with two standard enzyme datasets: the 
CATRES-FAM [52] of 140 enzymes with a total of 471 catalytic residues and the Catalytic 
Site Atlas(CSA-FAM)[53] of 94 enzymes, and was found to obtain 59% recall at precision 
18% for the first dataset and 51% recall at 18.5% precision for the second one. In predicting 
ligand-binding sites of 30 target proteins of CASP9 [54], fDPD gave 25 predictions with an 
average MCC value of 0.56, which ranked between 8th and 10th of the 33 participating 
groups[54].  
 
In this paper, we developed a knowledge-based method for prediction of PLIs on the basis of 
fDPD. For this sake, we first generated atomic PLI patterns associated with function sites 
protein domains in fDPD. Then we mapped PLIs of member proteins to pivotal sites of 
profile modules, thus derived a function-site- and PLI-annotated domain profile database, 
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called fiDPD. A similar hidden Markov model of HMMER program was then used to 
prediction between PFSs and PLIs for inquiry proteins. We applied fiDPD method to 10 
target proteins of CASP10[55] and CASP11[56], and found it gave correct PLIs for 80% of 
examined sites. This work is a substantial extension of the original fDPD method, and we 
expect it to be an auxiliary tool to conventional bioinformatics tools for protein function 
annotations. 
 
METHODS 
Figure 1 shows the flow chart to build fiDPD, which is an extension of fDPD by taking into 
account of PLIs. We firstly introduced the fDPD as a list of representative profile-modules 
which are built by sorting out structure-and-sequence similar protein-domains in SCOP 
databases[57]. Next PFSs and atomic patterns of PLIs were derived from known protein-
ligand-complex structures in PDB, and then, after a series of site-to-site mapping, they are 
used to annotate fDPD profile-modules and thus to build the fiDPD.  
 
Domain subgroups extracted from SCOP database are used to build fDPD. 
We started with a modified classification of protein-domain structures collected in the SCOP 
database[57, 58]. In SCOP, a big protein structure is often manually divided into a few 
smaller parts or domains, according to their spatial arrangement within the protein. A recent 
version of SCOPe 2.05 was download from http://scop.berkeley.edu/references/ver=2.05, 
which includes 214547 domain entries extracted from 75226 protein structures in PDB. In 
SCOP these domain structures are arranged in a hierarchical 7-level system: the Class (cl), 
the Fold (cf), the Superfamily (sf), the Family (fa), the Protein Domain (dm), the Species (sp), 
 7 
and the PDB code identity (px), according to their sequence, function and structure similarity. 
Particularly, those domains listed in a given domain entry (dm) presumably share the same 
class, same fold, same superfamily and same protein family, but might differ in species and 
PDB code-entry. Theoretically, PFSs are more likely to be conserved when they share both 
higher structural and sequential similarity, and this lays the basis for our algorithm of fiDPD 
in prediction of protein function-site and PLIs. Using a profile hidden Markov model of 
HMMER program, the multiple sequence alignment of all the domains within the same dm-
entry gives a single profile module representative. In this way, 12527 representative profile 
modules were created for all the dm-entries, which form the basis of fDPD and fiDPD.  
 
In building fDPD, it is important that protein domains within the same dm-entry are 
structurally and sequentially close enough to one another. However, a quick calculation 
reveals that the Cα root-mean-square-distance (RMSD) can be as large as 12Å or so for some 
domain structures listed in the same dm-entry. This result indicates that many domain 
structures in the same dm-entry of the original SCOPe 2.05 might be quite different, making 
the profile modules of fDPD being less representative of member proteins. To save this 
situation, we divided the domains within a dm-entry into a few smaller groups or subgroups 
so that selected domains within the same subgroup have mutual Cα-RMSD < 7Å and mutual 
sequence-similarity > 10 (a score value calculated by the multiple sequence alignment 
program of CLUSTRALW[59]). Thus derived subgroups are then replace the “dm”-entry as 
the basic unit of fDPD. fDPD contains 16559 subgroups, which is 32% more than the original 
SCOP dm-entries with about 12 member structures on average in each subgroup.  
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fDPD is a list of profile modules which are protein-domain representative.  
In fDPD, protein sequences of all domains in a subgroup were extracted and aligned using 
the multiple sequence alignment (MSA) program MUSCLE[60], from which a profile 
module was then built using the hmmbuild module of the HMMER 
program(http://hmmer.org/[61]). A profile module is a sequence of hypothetical amino acids, 
which is, instead of conventional amino acid, probably a mixture of certain amino acids 
according to the MSA of the subgroup. For each individual position in a profile module, we 
defined a conservation value C, according to the MSA. We assigned C value as 0, 1, 3, 4 for 
a position being non-conservative, little-conservative, conservative and highly conservative, 
as indicated respectively by gap, symbol “+”, small letter or capital letter in the MUSCLE 
alignment. We also defined an overall volume value N for a profile module as the number of 
protein domains listed in the subgroup: a larger N value usually means more knowledge 
available for that subgroup and thus greater confidence on the annotation.  
 
fDPD profile modules are annotated with function-sites of member proteins.  
A scoring function S was assigned to each position of an fDPD profile module to mark its 
propensity of being a function site. To do so, we first mapped known function-sites of 
member proteins within the same subgroup to the profile module, according to the MSA(see 
Figure 2). Function sites of member proteins were collected from the SITE sections of the 
corresponding PDB file. Of the 202705 protein domains listed in SCOPe 132725 domain 
structures have a total of 1878004 function-sites annotated in PDB SITE records. Then, for 
simplicity, we assigned S as the total hit-number that a profile module position receives 
based on the MSA. Thus, the larger a position has S value the more likely it might be a 
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hypothetical function site for the profile-module. In this way, the profile modules are 
annotated with known PFSs, thus called the function-site annotated domain profile database 
or fDPD. Previously, alternative function-site annotations for profile-modules were also built 
by using different “known” PFSs as derived from FDPA calculations[50].  
 
 
fiDPD was derived from fDPD by adding PLI annotations to the profile modules.  
 
Obviously, the above-mentioned S-value is heavily depended on the ways with which the 
“known” PFSs are determined. In this work, S-values are determined by only using PDB 
SITE information, which, in most case, are manually prepared ligand-binding sites. Other 
types of biologically-interested function-site data, such as enzyme active site[53], 
phosphorylation sites[62], etc., might also be used in the annotation. Here, considering the 
importance of PLIs in determining protein function, we added PLI annotations to the profile-
modules of fDPD, so as to build the function-site and interaction annotated domain profile 
database or fiDPD.   
 
To annotate the profile modules with PLIs, atomic interaction patterns between protein and 
ligand were firstly determined based on their 3D protein-ligand complex structures. 
Specifically, atomic 3D coordinates of amino acids listed in PDB SITE sections and those of 
ligand molecules were  firstly filtered out from PDB files, then a series of atomic distance (d) 
were calculated between PFSs (ASite) and ligands (ALigand), and finally a few types of bonding 
and non-bonding interactions for each ASite were determined based on the pair-wise distances 
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and the biochemical properties of involved amino acids.  
 
Covalent bond and coordinate bond Usually non-bonded forces dominate interactions 
between a ligand and its target protein, however irreversible covalent bonds are also found in 
PLIs when tight-and-steady connection between ligand and receptor is essential to the 
biological function, such as in the rhodopsin system[63]. A covalent bond is built if the 
distance between a non-hydrogen atom from a function site and a non-hydrogen atom from 
ligand satisfies , where  is the radius of atom A. For 
metal-ion ligands, this also defines coordinate bonds between metal ions and PFSs. Usually, 
in coordinate bonds the shared electrons are presented in atoms with higher electronegativity 
in a function site. We denoted NCOV as the total number of covalent bonds involving atoms 
in the function site, and NCOO as the total number of coordinate bonds involving atoms in 
that site.  
 
H-Bond Almost all PLIs occur in aqueous environment where water molecules play 
critical role. As a result, hydrogen bonds might be consistently established and destroyed 
until certain stable protein-ligand configuration is achieved. Here we have calculated 
hydrogen bonds within the protein-ligand complex using the program HBPLUS[64]. The 
program determines H-Bond donor (D) and acceptor (A) atom pairs based on a non-
hydrogen-atom configuration, using a maximum H–A distance of 2.5Å, maximum D–A 
distance of 3.9Å, minimum D–H–A angle of 90° and minimum H–A–AA angle 90°, where 
H is the theoretical Hydrogen atom, AA is the atom of function sites in H-bond acceptor. In 
this way, we defined NHBA and NHBD as the total number of H-bond acceptors and H-bond 
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donors associated with atoms in a given function site.  
 
Electrostatic interactions Electrostatic force plays important roles in many PLIs, and 
might be the main driving forces to initiate catalytic reactions, to guide the recognition 
between protein and ligand, and so on[65-67]. However, accurately determining atomic 
charges in bio-structure is a very challenging task since it is highly sensitive to the 
surrounding environment. Here, for simplicity, we identified electrostatic interactions simply 
by examining the charging status of contact atoms in PLIs. Specifically, we first selected 
positively charged nitrogen (N) atoms of function sites of Arg, His, and Lys, and then 
determined an electrostatic interaction if there exists a neighboring (< 4.5 Å) oxygen atom in 
ligand which is not a part of a cyclized structure. An electrostatic interaction was also built 
when a negatively charged oxygen (O) atom from Asp and Glu residues is found near a 
ligand nitrogen atom. We used NELE as the total number of electrostatic interactions 
involving atoms in a give function site.  
 
π-stacking interaction π-stacking interactions play critical role in orientating ligands 
inside binding pockets. We first identified aromatic side chains of Trp, Phe, Tyr and His of 
protein function-sites and carbon-dominant cyclized structures of ligands. Usually, aromatic 
rings form an effective π-stacking interaction when they get close enough (4.5~7Å) and 
have either parallel or perpendicular orientation[68, 69]. Here for simplicity, we defined a π
-stacking interaction if we can find three or more distinct heavy-atom-pairs between atoms 
from aromatic ring of given function site and those from ligand carbon-ring structures. We 
defined the total number of π-stacking interactions involving a given function site as NPI. 
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Van der Waals interaction  A Van der Waals interaction is built when the distance 
d between a non-hydrogen atom of protein function-site and a non-hydrogen atom of ligands 
satisfies, 
, 
where  is the van der Walls radius of atom A, and no covalent bond, coordination 
bond, hydrogen bond, electrostatic force and π-stacking interaction are found between them. 
The atomic van der Waals radii are taken from the CHARMM22 force-field[70]. Each 
function site was assigned a NVDW value as the total number of Van der Waals interactions 
involving atoms of this site.  
 
Taken together, we characterized a PLI between a PFS and the ligands with a 7-dimensional 
interaction vector v = (NCOV, NCOO, NHBA, NHBD, NPI, NELE, NVDW). Interaction 
vectors of all member protein were added up in different pivotal sites of the profile-module 
according to the MSA of the studied subroup. As a result, each fDPD profile-module was 
annotated with interaction vectors V’s on hypothetical function-sites, thus forming the fiDPD. 
 
fiDPD predicts functional sites and PLIs by a hidden Markov model.  
fiDPD is essentially a list of profile module entries that are annotated with domain function 
sites and PLIs. In fiDPD, a two-steps are required to predict hypothetical functional-sites and 
involved PLIs for a given enquiry protein: 1) identifying profile modules in fiDPD that match 
the inquiry sequence best, and 2) interpreting pivotal function sites and associated PLIs of the 
matched profile modules as a prediction of PFSs and PLIs for inquiry protein, based on 
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certain statistical evaluations.  
 
In the first step, fiDPD scans the inquiry sequence against all its module-entries, using the 
SCAN module of the HMMER program[71]. The scan usually gives a couple of profile 
modules within an alignment E-value cutoff no greater than 1×10-5. Each alignment (indexed 
by superscript j in Equation (1)) is assigned a scoring function E as the negative logarithm of 
the E-value score. Due to the limited volume of known protein sequences contained in fiDPD, 
there are cases in which HMMER SCAN cannot find any match for inquiry protein, and for 
these cases fiDPD simply gives a notice of “no-hit”. In step 2), we defined a scoring function 
Fi for the ith residue of the inquiry protein as its propensity to be a function-site:  
                                                     (1) 
where the summation runs over all the alignments j, and  stands for the position of profile 
module that matches the ith residue of inquiry protein. Residues with high-valued F-scoring 
function will be predicted as hypothetical functional sites.  
 
One way to determine high-F-valued sites for inquiry protein is simply to choose a certain 
number (n) of top-valued residues, called n-top selection. This method had been used for 
enzyme catalytic site prediction[50], since experimentally determined enzyme active sites 
have relatively fixed number as revealed by the dataset Catalytic Site Atlas (CSA)[53]. 
Another method to select top-valued residues uses a cutoff percentage that was proved to be 
efficient in a previous ligand-binding site prediction[72, 73]. In this method, we firstly 
filtered out those low-valued noise-like residues whose F-scores are smaller than a cut-off 
percentage  of the maximum F–value , and then, for the rest residues, the top  
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residues are predicted as hypothetical function-sites of the inquiry protein. Usually, in this 
selection strategy, a larger-sized protein tends to have more hypothetical function sites. We 
used this selection strategy to predict PFSs in the rest of this paper.  
 
To predict PLIs, we defined an interaction scoring-vector Ii for the ith residue of the inquiry 
protein, following Equation (1):  
                                                     (2) 
where  is interaction vector of the th position in the profile module j that corresponds to 
the ith residue of the inquiry sequence. For each prediction function site, fiDPD will 
determine an associate PLI vector according to Equation (2).  
 
Validation datasets 
The original fDPD had been examined for PFS prediction using a few types of datasets, 
including two manually cultivated enzyme-catalytic site datasets of 140-enzyme CATRES-
FAM[52] and 94-enzyme Catalytic Site Atlas (CSA-FAM)[53] and a 30-membered small-
molecular binding protein targets from CSAP9[74]. Here we examined fiDPD by calculating 
PLIs of protein targets listed in CASP10[75] and in CASP11[56] whose ligand-binding 
complex structures had been solved. 
 
Validation method  
The conventional prediction precision and recall were used to evaluate the performance of 
our method:  and , where the true 
positive (TP) is the predicted residues listed as functional sites in the dataset, the false 
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positive (FP) is the predicted not listed in the dataset, and the false negative (FN) is the 
functional sites listed in the dataset but missing by the method; another relevant quantity is 
the true negative (TN) that stands for the correctly predicted non-binding/non-functional site 
residues. In our calculations the statistics did not take account of the “no-hit” predictions. 
The overall precision is the sum of all the TPs divided by the total number of predicted 
residues, and the overall recall is  the sum of all the TPs divided by the total number of listed 
functional sites in the dataset. The precision-recall curve was found slightly dependent on the 
cutoff percentage M% and T% in the selection method. The Matthews correlation 
coefficient[76] (MCC) was used to assess the ligand-binding residue predictions of the 
CASP10 target proteins[54], which is defined as follows: 
. 
The predicted PLIs were compared with those directly derived from 3D protein-ligand 
complex structures, and a precision and recall value was obtained to qualify PLI predictions.  
 
RESULTS AND DISCUSSIONS 
 
The mimivirus sulfhydryl oxidase R596  
The 292aa mimivirus sulfhydryl oxidase R596 is target T0737 of CASP10 whose structure 
was later determined at 2.21Å (PDB entry 3TD7, see Figure 3[77]). The protein comprises of 
two all alpha-helix domains, the N-terminal sulfhydryl oxidase domain (Erv domain) and the 
C-terminal ORFan domain. The enzyme minivirus R596 has an EC number of EC1.8.3.2, 
catalyzing the formation of disulfide bonds through an oxidation reaction with the help of a 
cofactor of flavin adenine dinucleotide (FAD). FAD is found tightly bonded to 22 residues in 
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the catalytic pocket in Erv domain[55], playing an important role in transferring electrons 
from a 10Å-distance shuttle disulfide in the flexible inter-domain loop to the active-site 
disulfide close to FAD in Erv domain[77]. In the prediction, fiDPD scanned the T0737 
sequence against the database and found 4 profile module entries, all from the 
Apolipoprotein family with a structure of four-helical up-and-down bundle. The 4 entries 
include an automated-match-domain profile built from 10 sequences from Arabidopsis 
thaliana, a second automated-match-domain profile built from 4 sequences from Rattus 
norvegicus, an augmenter of liver regeneration domain profile built from 13 sequences from 
Rattus norvegicus, and a thiol-oxidase Erv2p domain profile built from 6 sequences from 
Saccharomyces cerevisiae. The scanning E-value ranges from 2×10-8 to 1×10-19, indicating 
that the inquiry sequence only has moderate similarity with the annotated sequences in the 
database. A total of 56 annotated pivotal sites in the 4 fiDPD profile modules were then 
collected and sorted according to their function-site scoring functions. When mapping to the 
inquiry sequence, 13 function sites were then automatically identified, which leads to a 100% 
prediction precision and 59% recall. We also examined those function sites that fiDPD failed 
to identify and found that they actually locate in a different C-terminal domain other than the 
four-helical up-and-down bundle domain. 
 
To examine the PLI prediction, we first collected interaction scoring-vectors associated 
pivotal sites in the four profile modules according Equation (2), and then compared with 
those directly determined from the protein-ligand complex structure recorded in PDB entry 
3TD7(Table 1). Figure 3 demonstrates key interactions predicted by Equation (2) and those 
not found by the prediction. fiDPD correctly predicted all the π-stacking interaction 
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involving Trp45, His49, Tyr114, His117, indicating that π-π interactions play critically 
important role in ligand binding. The prediction also found significant π-stacking interactions 
on pivotal sites of Leu78 and Lys123, however these π-π interaction predictions were 
ignored in a post-treatment simply because of lacking of aromatic side-chains in these 
residues. fiDPD also finds the correct electrostatic interactions on sites of His117 and Lys123. 
It identified large probability of electrostatic interactions on sites of Thr42 and Val126, 
however these interactions were ignored in a post-treatment since the involved residues are 
not chargeable in the conventional conditions.  Taken together, the overall PLI predictions 
associated with the identified function sites are about 80%.  
 
CASP10 Targets and CASP11 Targets   
We applied fiDPD to protein targets listed in CASP10 and CASP11, of which 13 targets had 
been solved to have explicit ligands bound[55]. Table 2 listed all the predictions, of which 
fiDPD gave no-hit for 3 target proteins. For the rest 10 predictions, fiDPD gave an overall 
precision of 87.7% and the overall recall of 59.9%, using a scale-selection with T% of 45% 
and M% of 35%. The averaged MCC of 0.66 which ranked between 4th and 5th of the 17 
participating groups[54]. Considering the ligand-binding types, we found that fiDPD gave 
better function-site predictions for metal binding sites with an averaged MCC value of 0.68 
while it is 0.46 for non-metal binding sites prediction, indicting that PFSs are more 
conservative with respect to either space arrangement or sequence location in metal binding.  
 
We examined the performance of fiDPD prediction of PLIs in these target proteins, by 
determining the overlap between the predicted PLIs and those calculated based on solved 
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protein-ligand complex structures.  Table 3 compared the predicted PLIs on function sites 
with the experiment PLIs. In most cases, fiDPD can correctly identified 80% or more of PLIs 
on function sites.   
 
 
Conclusions 
 
In this paper we presented a function-site- and PLI-annotated domain-profile database or 
fiDPD, from which we developed a sequence-based method for prediction of PFSs and PLIs. 
Our method is based on the belief that proteins that share similar structure and sequence tend 
to have similar functional sites located on the same positions on protein surface. A profile 
module entry in fiDPD is a representative of a bunch of protein domains that share high 
sequence-and-structure similarity as recorded in the SCOP database. For an inquiry protein, 
fiDPD method identifies profile modules in the database using the hidden Markov model 
algorithm of HMMER program, and then maps the annotated pivotal sites and associated 
PLIs of the profile modules to residues in the inquiry protein as a prediction.  
  
In earlier studies, fDPD method was examined in the prediction of catalytic sites of a 
standard dataset of 140-enzyme CATRES-FAM[52], resulted in an enzyme active-site 
prediction of 59% recall at a precision of 18.3%. For ligand-binding site prediction of target 
proteins in CASP9, fDPD obtained an averaged MCC of 0.56, ranking between 8th and 10th of 
the 33 participating groups[54]. fiDPD is identical to fDPD in prediction of PFSs, however, 
since its database is annotated with PLIs, fiDPD can give new prediction of PLIs on predicted 
 19 
function-sites. Here, fiDPD was applied to predict function sites of 10 target proteins in 
CASP10 and CASP 11 that have been solved in a ligand-bound state, and an averaged MCC 
of 0.66 was achieved. Further more, we compared the predicted PLIs with those directly 
calculated based on 3D protein-ligand-complex structures, and found that the predicted PLIs 
correctly overlap 80% of the true PLIs. Our calculations indicate that the PLIs are well-
conserved biochemical properties during the protein evolution, and it is possible to assign 
accurate PLIs on predicted PFSs using annotated database.   
 
There are a few ways to improve the performance of fiDPD predictions. First, adding new 
annotations to profile modules of fiDPD, which enable fiDPD to make new type of 
predictions. For example, mapping enzyme catalytic site (CSA), Zinc-binding sites, RNA-
binding sites to profile modules should largely improve fiDPD prediction of catalytic sites, 
Zinc-binding sites, RNA-binding sites. As a knowledge-based method, the utility and 
efficiency of fiDPD prediction suffers from the sampling limitation of annotations of known 
proteins. However, this sampling problem might be partially solved with the efforts of large 
scaled protein sequencing and the worldwide structure genomics projects. There still remains 
a challenge for protein function-annotation researcher to predict more and more detailed 
information about protein functioning, and to meet this task, it obviously needs the extensive 
cooperation between accurate theoretical modeling calculations and a large amount of 
experimental validations. fiDPD provides an example that atomic PLIs might be predicted 
from protein sequence, using a new type of function-site and PLI-annotated database.  
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Figure 1.  Flow-chart for building the function-site- and interaction-annotated domain profile 
database (fiDPD) and for predicting protein function-sites and PLIs using fiDSPD.  
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Figure 2.  Mapping known PFSs to profile module, : known PFSs of domain structures, : 
pivotal PFSs in a profile module with the number indicating a weight factor, PFSs mapped 
into the inquiry protein sequence from profile module pivotal sites, which, after a filtering, is 
reduced to two points (A and B) as a final prediction output,  non-conservative pivotal sites 
mapped into the inquiry protein, which will be ignored due to the low conservation value.  
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Figure 3. Mapping the protein-ligand interactions predicted for the mimivirus sulfhydryl 
oxidase R596, target T0737, PDB code 3TD7. Dash lines represent PLIs, they are colored as 
following: blue for electrostatic interactions, green for π-stacking interactions, gray for van 
der Waals interactions, and red for interaction not found by fiDPD.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. The prediction of protein-ligand interactions on PFSs of T0737†. 
 27 
 
Target Site AA COV COO ELE HBD HBA π-π 
T0737 
41 G 0 0 0 0 0 0 
42 T 0 0 +/0 T 0 0 
45 W 0 0 0 T 0 T 
49 H 0 0 0 0 + T 
78 L 0 0 0 0 0 0 
83 C 0 0 0 + T 0 
114 Y 0 0 0 0 T T 
117 H 0 0 T + - T 
118 N 0 0 0 + T 0 
120 V 0 0 0 0 0 0 
121 N 0 0 0 0 + 0 
123 K 0 0 T T + +/0 
 
 
†AA stands for amino acid, COV for covalent bond, COO for coordinate bond, ELE for electrostatic 
interaction, HBD for H-bond donor, HBA for H-bond acceptor, π-π for π-stacking interactions. “0” 
indicates the corresponding interaction is not present in protein-ligand complex structure and fiDPD 
calculation also showed no such type PLIs on the site. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Predictions of CASP10 targets proteins†. 
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Target PDB Ligand Type Sites Prediction TP Precision Recall MCC 
T0652 4HG0 AMP Non-metal 13 31 12 0.57 0.92 0.71 
T0657 2LUL ZN Metal 4 14 4 0.29 1 0.52 
T0659 4ESN ZN Metal 3 No-hit          
T0675 2LV2 ZN Metal 8 5 5 1 0.62 0.77 
T0686 4HQL MG Metal 3 2 2 1 0.67 0.81 
T0696 4RT5 NA Metal 3 2 2 1 0.67 0.81 
T0697 4RIT LLP Non-metal 14 11 10 0.91 0.71 0.8 
T0706 4RCK MG Metal 6 3 3 1 0.5 0.7 
T0720 4IC1 MN/SF4 Metal 14 No-hit          
T0721 4FK1 FAD Non-metal 31 3 3 1 0.1 0.3 
T0726 4FGM ZN Metal 3 No-hit          
T0737 3TD7 FAD Non-metal 22 13 13 1 0.59 0.76 
T0744 2YMV FNR Non-metal 19 4 4 1 0.21 0.45 
Average*          
 
† “Site ” stands for number of binding sites found the protein-ligand complex structures.  
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Table 3. PLI predictions of CASP10/11 targets proteins†. 
 
 
Target Interactions 
Correct 
Prediction 
Recall 
T0652 60 36 60% 
T0657 24 23 95.80% 
T0675 30 28 93.30% 
T0686 18 17 94.40% 
T0696 18 15 83.30% 
T0697 104 72 69.20% 
T0706 24 21 87.50% 
T0720 78 58 74.40% 
T0721 60 50 83.30% 
T0737 72 63 87.50% 
T0744 42 37 88.10% 
T0762 42 35 83.30% 
T0764 60 52 86.70% 
T0770 18 14 77.80% 
T0784 18 18 100% 
T0854 24 20 83.30% 
 
† Target 762 to 854 were taken from CASP11 whose protein-ligand interactions were well characterized in 
the crystal structures. 
 
 
 
